Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

perbB2-EGFP Citations (3)

Plasmid Article: Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane.
Offterdinger M, Bastiaens PI Traffic. 2008 Jan;9(1):147-55. Epub 2007 Nov 13.
PubMed Journal

Articles Citing perbB2-EGFP

Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases. Sommer AK, Hermawan A, Mickler FM, Ljepoja B, Knyazev P, Brauchle C, Ullrich A, Wagner E, Roidl A. Oncotarget. 2016 Aug 2;7(31):50461-50476. doi: 10.18632/oncotarget.10459. PubMed
A fully integrated, three-dimensional fluorescence to electron microscopy correlative workflow. Lopez CS, Bouchet-Marquis C, Arthur CP, Riesterer JL, Heiss G, Thibault G, Pullan L, Kwon S, Gray JW. Methods Cell Biol. 2017;140:149-164. doi: 10.1016/bs.mcb.2017.03.008. Epub 2017 Apr 19. PubMed
Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Shen M, Jiang YZ, Wei Y, Ell B, Sheng X, Esposito M, Kang J, Hang X, Zheng H, Rowicki M, Zhang L, Shih WJ, Celia-Terrassa T, Liu Y, Cristea I, Shao ZM, Kang Y. Cancer Cell. 2019 Jan 14;35(1):64-80.e7. doi: 10.1016/j.ccell.2018.11.016. Epub 2019 Jan 3. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.